793 related articles for article (PubMed ID: 26792170)
21. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
22. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
[TBL] [Abstract][Full Text] [Related]
23. In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.
Liang N; Sun S; Hong J; Tian J; Fang L; Cui F
Drug Deliv; 2016 Oct; 23(8):2651-2660. PubMed ID: 26165423
[TBL] [Abstract][Full Text] [Related]
24. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
Liang H; Yang Q; Deng L; Lu J; Chen J
Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948
[TBL] [Abstract][Full Text] [Related]
25. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
[TBL] [Abstract][Full Text] [Related]
26. Polymeric micelles with water-insoluble drug as hydrophobic moiety for drug delivery.
Li G; Liu J; Pang Y; Wang R; Mao L; Yan D; Zhu X; Sun J
Biomacromolecules; 2011 Jun; 12(6):2016-26. PubMed ID: 21568262
[TBL] [Abstract][Full Text] [Related]
27. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
[TBL] [Abstract][Full Text] [Related]
28. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
[TBL] [Abstract][Full Text] [Related]
29. α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
Liang N; Sun S; Li X; Piao H; Piao H; Cui F; Fang L
Int J Pharm; 2012 Feb; 423(2):480-8. PubMed ID: 22183133
[TBL] [Abstract][Full Text] [Related]
30. Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.
Cheng LC; Jiang Y; Xie Y; Qiu LL; Yang Q; Lu HY
Oncotarget; 2017 Jan; 8(2):3315-3326. PubMed ID: 27926514
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
Wang X; Guo Y; Qiu L; Wang X; Li T; Han L; Ouyang H; Xu W; Chu K
Carbohydr Polym; 2019 Feb; 206():121-131. PubMed ID: 30553305
[TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
34. Folate-decorated thermoresponsive micelles based on star-shaped amphiphilic block copolymers for efficient intracellular release of anticancer drugs.
Rezaei SJ; Nabid MR; Niknejad H; Entezami AA
Int J Pharm; 2012 Nov; 437(1-2):70-9. PubMed ID: 22884832
[TBL] [Abstract][Full Text] [Related]
35. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Lian H; Sun J; Yu YP; Liu YH; Cao W; Wang YJ; Sun YH; Wang SL; He ZG
Int J Nanomedicine; 2011; 6():3323-34. PubMed ID: 22228999
[TBL] [Abstract][Full Text] [Related]
36. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
37. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH
Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
39. Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.
Pei X; Luo F; Zhang J; Chen W; Jiang C; Liu J
Sci Rep; 2017 Apr; 7(1):975. PubMed ID: 28428562
[TBL] [Abstract][Full Text] [Related]
40. A micelle-shedding thermosensitive hydrogel as sustained release formulation.
de Graaf AJ; Azevedo Próspero dos Santos II; Pieters EH; Rijkers DT; van Nostrum CF; Vermonden T; Kok RJ; Hennink WE; Mastrobattista E
J Control Release; 2012 Sep; 162(3):582-90. PubMed ID: 22971272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
